New approach prevents thrombosis without increasing the risk of bleeding
Thursday, February 6, 2014 - 04:31
in Health & Medicine
In collaboration with an international team, researchers have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings.